Chemed Corp. 10-Q Summary: Quarter Ended June 30, 2000
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2000, and the six-month period ended June 30, 2000, for Chemed Corporation. The company operates primarily through four segments: Roto-Rooter (plumbing and drain cleaning), Patient Care (hospice services), Service America (home services), and Cadre Computer. The filing includes unaudited consolidated financial statements and management discussion.
Key Financial Metrics
| Metric | Q2 2000 | Q2 1999 | YTD 2000 | YTD 1999 |
|---|---|---|---|---|
| Service Revenues & Sales | $125.2M | $111.4M | $246.8M | $217.1M |
| Net Income | $6.1M | $5.1M | $11.0M | $10.5M |
| Diluted EPS | $0.61 | $0.49 | $1.10 | $1.00 |
| Operating Income | $9.2M | $6.2M | $16.7M | $12.0M |
| Operating Margin | 7.3% | 5.6% | 6.8% | 5.5% |
| Cash from Operations (YTD) | $17.6M (2000) vs $10.2M (1999) | |||
| Total Debt (Current + Long-Term) | $94.6M (June 30, 2000) vs $90.3M (Dec 31, 1999) | |||
| Cash & Equivalents | $14.5M (June 30, 2000) vs $17.3M (Dec 31, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 12% in Q2 and 14% YTD compared to the prior year. The Roto-Rooter segment drove this growth with a 19% increase in Q2 revenues, attributed to organic growth and acquisitions.
- Profitability: Net income rose 19% in Q2 and 5% YTD. Operating margins improved across the company, primarily due to the Roto-Rooter segment's margin expansion from 5.7% to 7.0%.
- Segment Performance: While Roto-Rooter margins improved, Patient Care and Service America margins declined due to higher interest costs, wage costs, and fuel/insurance expenses.
- Capital Structure: The company completed an Exchange Offer in February 2000, converting 575,503 shares of common stock into Mandatorily Redeemable Convertible Preferred Securities. This reduced stockholders' equity and increased current liabilities.
Outlook, Risks, and Management Commentary
- Liquidity: Management reports approximately $92.4 million in unused lines of credit and believes liquidity is satisfactory. The revolving credit agreement with Bank of America expires in June 2001 and is under negotiation for extension.
- Investment in Vitas Healthcare: Chemed holds a $27 million investment in Vitas Healthcare. Vitas paid dividends in arrears in June 2000. Management is negotiating repayment terms or an extension of the redemption date (currently May 1, 2001) but believes the investment is fully recoverable with no impairment.
- Acquisitions: Two businesses were acquired in Q1 2000 for $10.5 million, primarily allocated to goodwill. These are not expected to be material to 2000 results.
- Tax Rate: The effective tax rate decreased to 38.3% in Q2 2000 from 39.3% in Q2 1999, largely due to lower state and local tax rates.
Investor Verification Checklist
- Vitas Healthcare Status: Verify the outcome of negotiations regarding the $27 million preferred stock investment and the May 2001 redemption date.
- Debt Refinancing: Confirm the status of the revolving credit agreement extension expiring in June 2001.
- Segment Margins: Monitor the sustainability of margin compression in the Patient Care and Service America segments due to rising operational costs.
- Trust Securities: Review the terms of the $15.3 million Mandatorily Redeemable Convertible Preferred Securities issued in the February 2000 Exchange Offer.